249 related articles for article (PubMed ID: 34323402)
21. Global view of the RAF-MEK-ERK module and its immediate downstream effectors.
Santini CC; Longden J; Schoof EM; Simpson CD; Jeschke GR; Creixell P; Kim J; Wu X; Turk BE; Rosen N; Poulikakos PI; Linding R
Sci Rep; 2019 Jul; 9(1):10865. PubMed ID: 31350469
[TBL] [Abstract][Full Text] [Related]
22. Ligand-independent EPHA2 signaling drives the adoption of a targeted therapy-mediated metastatic melanoma phenotype.
Paraiso KH; Das Thakur M; Fang B; Koomen JM; Fedorenko IV; John JK; Tsao H; Flaherty KT; Sondak VK; Messina JL; Pasquale EB; Villagra A; Rao UN; Kirkwood JM; Meier F; Sloot S; Gibney GT; Stuart D; Tawbi H; Smalley KS
Cancer Discov; 2015 Mar; 5(3):264-73. PubMed ID: 25542447
[TBL] [Abstract][Full Text] [Related]
23. Proteogenomics of Malignant Melanoma Cell Lines: The Effect of Stringency of Exome Data Filtering on Variant Peptide Identification in Shotgun Proteomics.
Lobas AA; Pyatnitskiy MA; Chernobrovkin AL; Ilina IY; Karpov DS; Solovyeva EM; Kuznetsova KG; Ivanov MV; Lyssuk EY; Kliuchnikova AA; Voronko OE; Larin SS; Zubarev RA; Gorshkov MV; Moshkovskii SA
J Proteome Res; 2018 May; 17(5):1801-1811. PubMed ID: 29619825
[TBL] [Abstract][Full Text] [Related]
24. Melanoma proteomics suggests functional differences related to mutational status.
Trilla-Fuertes L; Gámez-Pozo A; Prado-Vázquez G; Zapater-Moros A; Díaz-Almirón M; Fortes C; Ferrer-Gómez M; López-Vacas R; Parra Blanco V; Márquez-Rodas I; Soria A; Fresno Vara JÁ; Espinosa E
Sci Rep; 2019 May; 9(1):7217. PubMed ID: 31076580
[TBL] [Abstract][Full Text] [Related]
25. Acquired BRAF inhibitor resistance: A multicenter meta-analysis of the spectrum and frequencies, clinical behaviour, and phenotypic associations of resistance mechanisms.
Johnson DB; Menzies AM; Zimmer L; Eroglu Z; Ye F; Zhao S; Rizos H; Sucker A; Scolyer RA; Gutzmer R; Gogas H; Kefford RF; Thompson JF; Becker JC; Berking C; Egberts F; Loquai C; Goldinger SM; Pupo GM; Hugo W; Kong X; Garraway LA; Sosman JA; Ribas A; Lo RS; Long GV; Schadendorf D
Eur J Cancer; 2015 Dec; 51(18):2792-9. PubMed ID: 26608120
[TBL] [Abstract][Full Text] [Related]
26. Integrative Exome and Transcriptome Analysis of Conjunctival Melanoma and Its Potential Application for Personalized Therapy.
Demirci H; Demirci FY; Ciftci S; Elner VM; Wu YM; Ning Y; Chinnaiyan A; Robinson DR
JAMA Ophthalmol; 2019 Dec; 137(12):1444-1448. PubMed ID: 31647501
[TBL] [Abstract][Full Text] [Related]
27. Mechanistic Analysis of an Extracellular Signal-Regulated Kinase 2-Interacting Compound that Inhibits Mutant BRAF-Expressing Melanoma Cells by Inducing Oxidative Stress.
Martinez R; Huang W; Samadani R; Mackowiak B; Centola G; Chen L; Conlon IL; Hom K; Kane MA; Fletcher S; Shapiro P
J Pharmacol Exp Ther; 2021 Jan; 376(1):84-97. PubMed ID: 33109619
[TBL] [Abstract][Full Text] [Related]
28. Identification of new protein coding sequences and signal peptidase cleavage sites of Helicobacter pylori strain 26695 by proteogenomics.
Müller SA; Findeiß S; Pernitzsch SR; Wissenbach DK; Stadler PF; Hofacker IL; von Bergen M; Kalkhof S
J Proteomics; 2013 Jun; 86():27-42. PubMed ID: 23665149
[TBL] [Abstract][Full Text] [Related]
29. Splice-Junction-Based Mapping of Alternative Isoforms in the Human Proteome.
Lau E; Han Y; Williams DR; Thomas CT; Shrestha R; Wu JC; Lam MPY
Cell Rep; 2019 Dec; 29(11):3751-3765.e5. PubMed ID: 31825849
[TBL] [Abstract][Full Text] [Related]
30. Immune Responses to BRAF-Targeted Therapy in Melanoma: Is Targeted Therapy Immunotherapy?
Kelley MC
Crit Rev Oncog; 2016; 21(1-2):83-91. PubMed ID: 27481005
[TBL] [Abstract][Full Text] [Related]
31. Using quantitative proteomic analysis to understand genotype specific intrinsic drug resistance in melanoma.
Koomen JM; Smalley KS
Oncotarget; 2011 Apr; 2(4):329-35. PubMed ID: 21505227
[TBL] [Abstract][Full Text] [Related]
32. Platform-independent and label-free quantitation of proteomic data using MS1 extracted ion chromatograms in skyline: application to protein acetylation and phosphorylation.
Schilling B; Rardin MJ; MacLean BX; Zawadzka AM; Frewen BE; Cusack MP; Sorensen DJ; Bereman MS; Jing E; Wu CC; Verdin E; Kahn CR; Maccoss MJ; Gibson BW
Mol Cell Proteomics; 2012 May; 11(5):202-14. PubMed ID: 22454539
[TBL] [Abstract][Full Text] [Related]
33. High-throughput database search and large-scale negative polarity liquid chromatography-tandem mass spectrometry with ultraviolet photodissociation for complex proteomic samples.
Madsen JA; Xu H; Robinson MR; Horton AP; Shaw JB; Giles DK; Kaoud TS; Dalby KN; Trent MS; Brodbelt JS
Mol Cell Proteomics; 2013 Sep; 12(9):2604-14. PubMed ID: 23695934
[TBL] [Abstract][Full Text] [Related]
34. Top Down Proteomics Reveals Mature Proteoforms Expressed in Subcellular Fractions of the Echinococcus granulosus Preadult Stage.
Lorenzatto KR; Kim K; Ntai I; Paludo GP; Camargo de Lima J; Thomas PM; Kelleher NL; Ferreira HB
J Proteome Res; 2015 Nov; 14(11):4805-14. PubMed ID: 26465659
[TBL] [Abstract][Full Text] [Related]
35. The effects of p53 gene inactivation on mutant proteome expression in a human melanoma cell model.
Faktor J; Grasso G; Zavadil Kokas F; Kurkowiak M; Mayordomo MY; Kote S; Singh A; Ruidong L; O'Neill JR; Muller P; Goodlett D; Vojtesek B; Hupp T
Biochim Biophys Acta Gen Subj; 2020 Dec; 1864(12):129722. PubMed ID: 32866596
[TBL] [Abstract][Full Text] [Related]
36. High-Throughput Profiling of Proteome and Posttranslational Modifications by 16-Plex TMT Labeling and Mass Spectrometry.
Yu K; Wang Z; Wu Z; Tan H; Mishra A; Peng J
Methods Mol Biol; 2021; 2228():205-224. PubMed ID: 33950493
[TBL] [Abstract][Full Text] [Related]
37. Proteome-wide onco-proteogenomic somatic variant identification in ER-positive breast cancer.
Dimitrakopoulos L; Prassas I; Sieuwerts AM; Diamandis EP; Martens JWM; Charames GS
Clin Biochem; 2019 Apr; 66():63-75. PubMed ID: 30684468
[TBL] [Abstract][Full Text] [Related]
38. Clinical protein science in translational medicine targeting malignant melanoma.
Gil J; Betancourt LH; Pla I; Sanchez A; Appelqvist R; Miliotis T; Kuras M; Oskolas H; Kim Y; Horvath Z; Eriksson J; Berge E; Burestedt E; Jönsson G; Baldetorp B; Ingvar C; Olsson H; Lundgren L; Horvatovich P; Murillo JR; Sugihara Y; Welinder C; Wieslander E; Lee B; Lindberg H; Pawłowski K; Kwon HJ; Doma V; Timar J; Karpati S; Szasz AM; Németh IB; Nishimura T; Corthals G; Rezeli M; Knudsen B; Malm J; Marko-Varga G
Cell Biol Toxicol; 2019 Aug; 35(4):293-332. PubMed ID: 30900145
[TBL] [Abstract][Full Text] [Related]
39. Human Proteomic Variation Revealed by Combining RNA-Seq Proteogenomics and Global Post-Translational Modification (G-PTM) Search Strategy.
Cesnik AJ; Shortreed MR; Sheynkman GM; Frey BL; Smith LM
J Proteome Res; 2016 Mar; 15(3):800-8. PubMed ID: 26704769
[TBL] [Abstract][Full Text] [Related]
40. Genomic and transcriptomic landscape of conjunctival melanoma.
Cisarova K; Folcher M; El Zaoui I; Pescini-Gobert R; Peter VG; Royer-Bertrand B; Zografos L; Schalenbourg A; Nicolas M; Rimoldi D; Leyvraz S; Riggi N; Moulin AP; Rivolta C
PLoS Genet; 2020 Dec; 16(12):e1009201. PubMed ID: 33383577
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
